Fig. 4
From: Long-term efficacy of subtotal splenectomy due to portal hypertension in cirrhotic patients
a Changes in the white blood cell (WBC) count and platelet count at 6- and 11- years, after SSFROM for PHT (*P < 0.01). b Change in portal venous diameter at 6- and 11- years, after SSFROM for PHT (*P < 0.01). c Changes in portal venous flow volume, and splenic artery flow volume at 6- and 11- years, after SSFROM for PHT (*P < 0.01). d Changes in splenic length and splenic thickness at 6- and 11- years, after SSFROM for PHT (*P < 0.01). e Change in splenic square area. at 6- and 11- years, after SSFROM for PHT (*P < 0.01). f Changes in levels of serum IgA, IgM and IgG at 6 and 11 years, after SSFROM for PHT (*P > 0.05). g Change in levels of serum Tuftsin at 6 and 11 years, after SSFROM for PHT (*P > 0.05). h Changes in levels of serum macrophage colony-stimulating factor (M-CSF) and granulocyte-macrophage colony-stimulating factor and (GM-CSF) at 6 and 11 years, after SSFROM for PHT (*P < 0.01). i Changes in proportion of serum CD3+ T cells, CD4+ T cells, and CD8+ T cells at 6 and 11 years, after SSFROM for PHT (*P < 0.01)